MFG
TXG icon

Merit Financial Group’s 10x Genomics TXG Stock Holding History

Merit Financial Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
40,696
+5,525
+16% +$145K 0.01% 860
2026
Q1 		$747K Buy
35,171
+1,638
+5% +$32.7K 0.01% 1141
2025
Q4 		$547K Sell
33,533
-687
-2% -$10.4K ﹤0.01% 1267
2025
Q3 		$400K Sell
34,220
-97
-0.3% -$1.26K ﹤0.01% 1302
2025
Q2 		$397K Buy
+34,317
New +$313K ﹤0.01% 1205

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Merit Financial Group's TXG Position: Q2 2026 in Review

Merit Financial Group increased its 10x Genomics (TXG) stake by 16% in Q2 2026, buying an estimated $145K and bringing the position to 40,696 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #860.

Merit Financial Group first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Merit Financial Group held 40,696 shares of 10x Genomics worth $1.56M as of Q2 2026.
  • Merit Financial Group bought 5,525 10x Genomics shares in Q2 2026, an estimated $145K.
  • 10x Genomics made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #860 holding.
  • Merit Financial Group first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.